Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era
Description
CONCLUSION: We identified COVID-19 infections after T/C prophylaxis. Among patients who received T/C at our institution, COVID-19 Omicron cases occurring after T/C were one-fourth as likely to require hospitalization compared to those with Omicron